Our central research topic is the study of structure-function relationships in signaling enzymes, with a focus on protein tyrosine phosphatases. The aim is to contribute to the understanding of how their structural features are correlated with specific signaling functions. To this end, signaling enzymes are studied from several directions:
The combination of results thus obtained in this way is further used to shed light on the signaling mechanism and overall functional role of the given enzyme.
We have good experience and we are currently involved in the production, isolation and purification of recombinant proteins, expressed in both prokaryotic and eukaryotic systems. Our research activity is carried out through tools of molecular biology (recombinant DNA, site-directed mutagenesis, (RT)-PCR, Western blot, immunoprecipitation, etc.), spectroscopic analysis (UV-VIS and fluorescent spectrophotometry), cell biology, protein crystallization and enzyme kinetics.
Our ongoing research projects are:
Current research directions:
(a) expression, purification and study of the mechanism of action of some proteins involved in synaptic transmission;
(b) creation of new conjugates based on afibodies with a potential therapeutic role in different forms of leukemia;
(c) biochemical study of tau protein acetylation with applicability in neurodegenerative diseases;
(d) study of signaling mechanisms involved in various cancer forms
RECENT PUBLICATIONS:
The main idea of this project was that by inhibiting at least one of these two interactions of GluA2, the internalization of AMPAR will be reduced and therefore the synapse resistance will be increased, thus leading to improved cognitive functions.
The project is agreed as a bilateral collaboration between IBAR and ATOMKI, and the University of Debrecen and IFIN-HH participate in this project voluntarily.
The project is agreed as a joint collaboration among IBAR, ATOMKI and UD, the latter being a cost free participant. There are two main directions envisaged by the proposed project: - receptors mapping and therapy, using an affibody against HER2 receptors, combined with an adequate radioisotope. In this respect, the specific objectives are: a) expression and purification of affibodies; b) establishing labelling procedures; c) ex vivo and/or in vivo testing of optimal compounds.
Affibody molecules are highly promising therapeutic candidates due to their advantageous features like: small size, efficient delivery, straightforward engineering towards improved formats, site-directed conjugation of payloads, possibility of GMP production by chemical synthesis or inexpensive bacterial production leading to low product costs.
Project Funded under: Human resources and Mobility in the specific programme for research, technological development and demonstration "Structuring the European Research Area" under the Sixth Framework Programme 2002-2006. PTPNET was a Training Network for young scientists in the field of protein tyrosine phosphatase (PTP) research.
Proteins are essential players of all biological processes and they are involved in practically every function performed by a living cell.
The Alexander von Humboldt Foundation promotes academic cooperation between foreign and German researchers at the highest level. Each year, the Foundation awards more than 700 research fellowships and awards to support researchers from abroad who come to Germany to work on a research project together with German researchers at a host institute. The research topic is chosen by the applicant.
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is the most important independent research funding organisation in Germany. It supports both scientific and humanistic studies and aims to promote top-level research in various disciplines at universities and research institutions. The main focus is on funding projects proposed by the scientific community, with an emphasis on knowledge-driven research.
Proteins are the most important functional units of living matter: all cellular processes are governed by specific proteins possessing highly specialized functional roles. Understanding the intimate mechanisms of cell functions necessitates a detailed knowledge of the 3D-structure of proteins.
One of the most powerful techniques in modern biomedical research is the determination of the three dimensional structure of proteins. This project proposes to establish a laboratory for 3D protein structure determination using X-ray diffraction experiments.
Protein tyrosine phosphatases (PTPs) are fundamental regulatory enzymes that dephosphorylate phosphotyrosine residues and are essential components of intracellular signalling pathways in both normal and pathological conditions. There is experimental evidence that disruption of the phosphatase activity of many PTPases is involved in the pathogenesis of several congenital or acquired diseases, including diabetes, cancer, infections, autoimmune, neuronal and cardiovascular diseases.
The project focuses on characterizing the branchio-oto-renal (BOR) syndrome, an autosomal dominant genetic disorder caused by mutations in the EYA gene. The goal is to enzymatically analyze the conserved C-terminal domain of the Eya3 protein and identify physiological substrates to better understand the molecular mechanisms involved in this syndrome.
Cancer causes 1.5 million deaths a year in Europe, accounting for a quarter of all deaths. The incidence of cancer is increasing, with 20 million new cases and 10 million deaths expected in the next 20 years. Approximately 90% of deaths are due to metastases rather than primary tumours. Genetic mutations and genomic instability allow tumour cells to invade and form metastases.
This project aims to develop a highly efficient enzyme for the conversion of xylose from cellulosic wastes into high-value biosynthetic intermediates. By optimising the catalytic efficiency of phosphoketolase and designing an enzymatic reactor, the project aims to provide a sustainable method of utilising lignocellulosic residues.
![]() |
![]() |
Development of a cyclotron-driven neutron activator for radiopharmaceutical production: a case study of holmium-166-labelled Affibody for targeted diagnosis and therapy
Project code / Contract: PN-III-P2-2.1-PED-2019-4184; 548/PED/02.11.2020
Coordinator: IFIN-HH; Dr. Liviu Ștefan Crăciun
IBAR role: Research partner; Dr. Ștefan-Eugen Szedlacsek (IBAR project lead)
IBAR budget: 250.000 RON (≈ 51.684 EUR)
Project period: 02.11.2020 - 31.10.2022
The project investigated a compact cyclotron-driven neutron activator and the potential use of holmium-166-labelled, HER2-targeting Affibody molecules for targeted cancer imaging and therapy.
Scientific coordinator: Dr. Ștefan-Eugen Szedlacsek
Researchers: Dr. Rodica-Aura Badea; Dr. Horea Szedlacsek
PhD students: Adina-Gabriela Puiu; Andrei-Mihai Vasilescu
Assistants: Cătălin C. Bica; Otilia-Cristina Donțu
Publication: Authors: Balázs Váradi, Károly Brezovcsik, Zoltán Garda, Enikő Madarasi, Horea Szedlacsek, Rodica-Aura Badea, Andrei-Mihai Vasilescu, Adina-Gabriela Puiu, Aura Ionescu, Livia-Elena Sima, Cristian V. A. Munteanu, Simona Călăraș, Adrienn Vágner, Dezső Szikra, Ngô Minh Toàn, Tibor Nagy, Zoltán Szűcs, Ștefan-Eugen Szedlacsek. “Synthesis and characterization of a novel [52Mn]Mn-labelled affibody based radiotracer for HER2+ targeting”. Inorganic Chemistry Frontiers (2023). DOI: 10.1039/D3QI00356F.
Official project website: Coordinator's project page
![]() |
![]() |
Genomic mapping of population from polluted area with radioactivity and heavy metals to increase national security
Project code / Contract: PN-III-P1-1.2-PCCDI-2017-0737; 35/PCCDI/03.04.2018
Coordinator: UMF „Iuliu Hațieganu”, Cluj-Napoca; Prof. Dr. Ioana Berindan-Neagoe
IBAR role: Research partner 3; Dr. Ștefan-Eugen Szedlacsek (IBAR project lead)
IBAR budget: 939.600 RON (≈ 201.913 EUR)
Project period: 03.04.2018 - 31.12.2021
ARTEMIS studied the potential relationship between environmental exposure to radioactive substances and heavy metals and molecular changes associated with cancer in North-West Romania. The consortium focused on genomic and molecular profiles relevant to lung, thyroid and colorectal cancer.
The Department of Enzymology contributed to the selection of tumor protein markers and related peptides and their mass-spectrometric investigation in blood plasma samples from cancer patients and healthy controls.
Project lead: Ștefan-Eugen Szedlacsek 2018-2021
Scientific researcher: Aura-Elena Ionescu 2018-2021
Research assistant: Horea-Ștefan Szedlacsek 2019-2021
Research assistant: Viorel Enache 2019-2020
Research assistant: Simona Călăraș 2019-2020
Research assistant / PhD student: Adina-Gabriela Puiu 2020-2021
Research assistant / PhD student: Andrei-Mihai Vasilescu 2021
Administrative support: Otilia-Cristina Donțu 2018-2021
Publication: “Biological and molecular modifications induced by cadmium and arsenic during breast and prostate cancer development”. Authors: Alina-Andreea Zimta, Vlad Schitcu, Eugen Gurzau, Crina Stavaru, Gina Manda, Ștefan-Eugen Szedlacsek, Ioana Berindan-Neagoe. Environmental Research, vol. 178, article 108700 (2019). DOI: 10.1016/j.envres.2019.108700.
ARTEMIS workshop (2020): Speaker: Aura-Elena Ionescu. “Mass spectrometric analysis of differential protein expression in the blood plasma of healthy versus cancerous individuals from radioactively and/or heavy metal contaminated regions”. Authors: Aura-Elena Ionescu, Simona Călăraș, Doina Piciu, Ștefan-Eugen Szedlacsek.
![]() |
![]() |
The development in oncology of novel radiopharmaceuticals and nuclear techniques for diagnostic imaging and personalized treatment at molecular level
Project code / Contract: PN-III-P1-1.2-PCCDI-2017-0769; 64/PCCDI/31.03.2018
Coordinator: IFIN-HH; Dr. Mihai Ciubotaru
IBAR role: Research partner 1; Dr. Ștefan-Eugen Szedlacsek (IBAR project lead)
IBAR budget: 404.475 RON (≈ 86.918 EUR)
Project period: 31.03.2018 - 30.09.2021
ONCORAD brought together research institutions and clinical partners to develop targeted radiopharmaceuticals and nuclear medicine techniques for molecular diagnostic imaging and personalized cancer treatment. The programme included research on relevant molecular markers, preclinical imaging approaches and the assessment of novel radiolabelled compounds.
The Institute of Biochemistry of the Romanian Academy, through its Department of Enzymology, participated as a research partner in ONCORAD, contributing to shared research objectives related to molecular biomarkers and their potential applications in cancer diagnosis.
Partner project manager: Dr. Ștefan-Eugen Szedlacsek 2018 - 2021
Scientific researcher: Dr. Rodica-Aura Badea 2018 - 2021
Scientific researcher: Dr. Sorin Tunaru 2019 - 2021
Research assistant / PhD student: Alexandra-Maria Bănică 2019 - 2021
Assistant: Adina-Mariana Monea 2018
Assistant: Cătălin-Constantin Bica 2020
Administrative and financial support: Otilia-Cristina Donțu 2018 - 2021
In Project 1, the consortium investigated markers associated with myeloid cell differentiation and leukemia, including Ly6C and ScaI, and examined their potential use in experimental imaging.
Official final project results: IFIN-HH - ONCORAD (PDF) · IFIN-HH - project page
![]() |
![]() |
"V(D)J recombination targeted in cis by transcription induced DNA supercoiling"
Project code / Contract: PNII-ID-PCE-2011-0024; 2/02.06.2012
Coordinator: IFIN-HH; Dr. Mihai Ciubotaru
IBAR role: Research partner 1; Prof. Dr. Ștefan-Eugen Szedlacsek (IBAR project lead)
IBAR budget: 888.921 RON (≈ 199.489 EUR)
Project period: 02.07.2012 - 01.12.2016
The project investigated how transcription-induced DNA supercoiling influences V(D)J recombination, a key process for generating the diversity of antigen receptors in B and T lymphocytes. The research examined RAG-mediated pairing and cleavage at recombination signal sequences (RSSs), including the effects of DNA topology and the orientation of recombination sites.
Partner manager: Dr. Ștefan-Eugen Szedlacsek
Postdoctoral researchers: Dr. Rodica-Aura Badea 2014 - 2016
Dr. Ioana Popa: 2013
Dr. Sandu Taras: 2013
PhD students: Kibedi Szabo-Csaba 2013
Bogdan Ivănuș: 2013 - 2015
Research assistant: Dora-Domnica Popescu 2015
Administrative assistant: Otilia-Cristina Donțu 2015 - 2016
Official project page: IFIN-HH - Idei complexe
![]() |
![]() |
Preclinical model of cell therapy employing protein tyrosine phosphatase-microRNA interplay to optimize neovascularization
Project code / Contract: PN-II-PT-PCCA-2011-3.1-0688; 79/02.07.2012
Coordinator: Institute of Cellular Biology and Pathology „Nicolae Simionescu”; Dr. Marilena Lupu / Dr. Alexandrina Burlacu
IBAR role: Research partner 1; Prof. Dr. Ștefan-Eugen Szedlacsek (IBAR project lead)
IBAR budget: 600.000 RON (≈ 134.650 EUR)
Project period: 02.07.2012 - 01.12.2016
THERION aimed to develop a personalized preclinical model for evaluating the ability of endothelial colony-forming cells (ECFCs) to induce neovascularization in cardiac tissue. The project investigated how protein tyrosine phosphatases (PTPs) and microRNAs (miRNAs) contribute to cell differentiation and the formation of new blood vessels.
Partner project manager: Prof. Dr. Ștefan-Eugen Szedlacsek
Scientific researchers: Dr. Georgiana Petrăreanu (2012-2016); Dr. Rodica-Aura Badea (2012-2013)
PhD student: Kibédi Szabó-Csaba (2012)
Research assistants: Larisa Maier (2013-2014); Adela Mocanu (2015)
Assistants: Adina-Mariana Monea (2013-2015); Otilia-Cristina Donțu (2015-2016)
1. “The molecular and cellular characterization of a non-receptor protein tyrosine phosphatase”.
Author: Georgiana Petrăreanu. Romanian Journal of Biochemistry, 50(1), 65-72 (2013).
2. “Collagen regulates the ability of endothelial progenitor cells to protect hypoxic myocardium through a mechanism involving miR-377/VE-PTP axis”.
Authors: A.M. Roșca, D.N. Mitroi, V. Cișmașiu, R. Badea, G. Necula-Petrăreanu, M.B. Preda, C. Niculițe, R. Tuțuianu, Ș. Szedlacsek, A. Burlacu. Journal of Cellular and Molecular Medicine, 22, 4700-4708 (2018). PubMed.
“Expression, Purification, and Kinetic Analysis of PTP Domains”.
Authors: Mihaela Mentel, Rodica A. Badea, Georgiana Necula-Petrăreanu, Sujay T. Mallikarjuna, Aura E. Ionescu, Ștefan E. Szedlacsek. In Protein Tyrosine Phosphatases, pp. 39-66 (2016). ISBN 978-1-4939-3744-8.
4-6 June 2014, Băile Felix, Romania. Annual Conference of the Romanian Society of Biology and Molecular Biochemistry. Poster: “Assessment of the expression of PTPs potentially involved in endothelial progenitor cells differentiation and angiogenesis”.
Authors: Rodica-Aura Badea, Georgiana Petrăreanu, Ștefan-Eugen Szedlacsek.
17-18 September 2015, Bucharest, Romania. SRBBM 25th Anniversary Conference. Poster: “Modulation of the expression of protein tyrosine phosphatases involved in endothelial progenitor cells differentiation”.
Authors: Rodica-Aura Badea, Georgiana Petrăreanu, A.M. Roșca, Ștefan-Eugen Szedlacsek.
Official project website: Institute of Cellular Biology and Pathology - THERION
Outstanding researchers who have made a significant contribution to the advancement of knowledge in their field, demonstrating the importance of the solid foundation provided by the Department of Enzymology in their professional training.
1995-2005

During this period, the Department of Enzymology at theInstitute of Biochemistry was characterised by innovative research that had a profound impact on the scientific field. The research team made remarkable progress in various fields of biology and medicine, contributing significantly to the understanding of the molecular mechanisms of diseases, the development of innovative genetic therapies and the elucidation of the structure of proteins involved in pathological processes. One of the most notable achievements of this period was the first successful cloning in Romania, made possible by the diligent work and close collaboration of Radu Aricescu, Valeriu Bogdan Cișmașiu, Tudor Fulga and Ștefan Szedlacsek.
This major achievement involved the synthesis of the nucleotide sequence and its cloning into a prokaryotic expression vector, followed by the expression, purification and characterisation of the resulting protein. This collaborative effort opened new perspectives in the understanding of molecular mechanisms and advanced knowledge in structural biology. The successful cloning of a tyrosine phosphatase receptor protein was a milestone in the department's research.
These researchers demonstrated that through collaboration and perseverance, major innovations are possible and their impact is felt not only in Romania, but throughout the international scientific community. Their work opened up new avenues of research and had a global impact, collaborating with prestigious institutions around the world. Their results have been instrumental in advancing knowledge in enzymology and molecular biology, laying the foundations for future research and positively influencing the international scientific community.
2005 - 2015
Another generation of talented researchers has been involved in advanced studies to elucidate the structure and function of essential proteins using X-ray diffraction and super-resolution microscopy techniques. They participated in studies investigating the substrates of EYA3 phosphatase and how its dephosphorylation influences changes in the actin cytoskeleton, with results published in the prestigious journal Scientific Reports.
They have contributed to the understanding of the enzymatic properties and substrate specificity of phosphoketolases from several bacteria, including Lactococcus lactis, Leuconostoc mesenteroides and Pseudomonas aeruginosa. These studies have provided essential biochemical and kinetic data for the application of these enzymes in biotechnological processes.
2015 -2023